The Short Version
Multiple systematic reviews and meta-analyses — including a 2025 BJPsych Open analysis of 15 studies — consistently show ashwagandha reduces perceived stress and cortisol levels compared to placebo. However, these benefits are best demonstrated in chronically stressed adults, not the general population. Evidence certainty is rated "low" with high heterogeneity across trials, at least one RCT found no cortisol effect in a specific subgroup, and long-term safety data remain limited. The claim is substantively supported but overstates universality.